ResearchMoz

Competitive Analysis Market Research Reports & Industry Analysis

In a business environment, an activity such as competitive analysis is amongst the healthiest of events because companies learn about the competition’s weaknesses and strengths in every business sense. This way a company can plan or act strategically thereafter. It is highly imperative to know what your competitors are doing, where they are in the business competition, etc. 

An extensive analysis helps you gather and analyze all the key information about your competitors, strengths, practices, products, business trends, and weaknesses in order to determine your market position and improve your services and products worldwide. 

Companies actively participating in competitive analysis simply shows investors that they are aware of the market competition, the marketplace, its strategies, and have definitely planned a stratagem to compete at the same level as other established competitors in the industry would do. 

However, to get ahead in business and market, companies need to take care of several things including describing the services or products they offer in the industry, heir strategic plans to compare to what the competition brings to the market, and most importantly doing a SWAT analysis of the key competitors. 

Such assessments of weaknesses and strengths in business environments can help in identifying various opportunities for improvement and in turn gain comprehensive analysis of every competitor in the industry. 

Competitive analysis extends basic help in allowing you to deal with potential threats even before they arise. It gives you a realistic view of your competition. 

To illustrate this process, ResearchMoz reports act as your constant source of information and guidance in helping you gain a competitive advantage in the market. You need knowledge, a clear picture about the process of competitive analysis, or any further data on this subject, our exclusive market research reports created by our team of experts tell you what’s happening in the market and where. 

So, rely on us to gain quick tips on competitive intelligence because our insights, reports, and market analysis definitely enable you to differentiate yourself from other competition in the industry, protecting your revenue and securing your position in return.  
Competitive Analysis

Browse reports in Competitive Analysis

Displaying 1 to 30 (of 1534 records)
Global and China Logo Industry 2014 Market Research Report
Mar 2014   |   By - QYResearch
The report firstly introduced Logo basic information included Logo definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Logo industry policy and plan, Logo product specification, manufacturing process, product cost structure...
$2200
Global and China Hub Logo Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Hub Logo basic information included Hub Logo definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Hub Logo industry policy and plan, Hub Logo product specification, manufacturing process,...
$2200
Amazon, QVC Inc., Sears Holding Corp, Valve Corp. - Company Analysis, SWOT, Marketing Strategy
Aug 2013   |   By - Renub Research
The online retail industry is one of the most progressive sectors of the United States. Online shopping has opened up huge new choices for consumers, not just in terms of what they buy, but how they buy it. The Internet has empowered the consumer in three ways: during the decision-making process leading to the purchase; at the actual moment of purchase; and throughout the product...
$750
Global Web Content Management Systems Market 2012-2016
Jul 2013   |   By - Technavio
TechNavio's analysts forecast the Global Web Content Management Systems market 2012-2016 to grow at a CAGR of 12.87 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand from small and medium-sized enterprises. The market has also been witnessing the emergence of SaaS-based web content management systems. However, the lack of...
$2500
Johnson & Johnson / Janssen Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Johnson & Johnson and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D...
$995
Merck & Co Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Merck & Co and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot...
$995
Merck KGaA / Merck Serono Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Merck KGaA and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
Mitsubishi Tanabe Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Mitsubishi Tanabe and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A...
$995
Mylan Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Mylan and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
Otsuka Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Otsuka and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
Pfizer Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Pfizer and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
Shionogi Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Shionogi and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A...
$995
Shire Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Shire and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot...
$995
Stada Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Stada and its partnering interests and activities over the past seven years.  One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies....
$995
Takeda Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Takeda and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot...
$995
Teva Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Teva and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot...
$995
UCB Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand UCB and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
Valeant Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A...
$995
Warner Chilcott Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Warner Chilcott and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D...
$995
Multiple Sclerosis Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Multiple Sclerosis Partnering 2007-2013 provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies . The report provides an analysis of multiple sclerosis disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option...
$995
Crohn's Disease Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Crohn's Disease Partnering 2007-2013 report provides understanding and access to the crohn's disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in crohn's disease partnering deals Top crohn's disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The...
$995
Gastrointestinal Symptoms Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Gastrointestinal Symptoms Partnering 2007-2013 report provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastrointestinal symptoms partnering deals Top gastrointestinal symptoms deals by value Deals listed by company A-Z, industry sector, stage of...
$995
Genetic Disorders Partnering Terms and Agreements
Jul 2013   |   By - Current Partnering
The Genetic Disorders Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter genetic disorders partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with...
$2995
Immunology Partnering Terms and Agreements
Jul 2013   |   By - Current Partnering
The Immunology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the immunology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are discovery or...
$2995
Inflammatory Partnering 2007-2013
Jul 2013   |   By - Current Partnering
Inflammatory Partnering 2007-2013 report provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in inflammatory partnering deals Top inflammatory deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Inflammatory Partnering...
$1795
E.coli Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The E-coli Partnering 2007-2013 provides understanding and access to the e-coli partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of e-coli partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors e-coli...
$995
Influenza Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Influenza Partnering 2007-2013 provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of influenza partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors...
$1795
Dry Eye Partnering 2007-2013
Jul 2013   |   By - Current Partnering
Dry Eye Partnering 2007-2013 report provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dry eye partnering deals Top dry eye deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Dry Eye Partnering 2007-2013 provides...
$995
Attention Deficit Hyperactivity Disorder Partnering 2007-2013
Jul 2013   |   By - Current Partnering
The Attention Deficit Disorder Partnering 2007-2013 provides understanding and access to the attention deficit disorder partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of attention deficit disorder partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right...
$995
Aspen Partnering 2005-2013
Jul 2013   |   By - Current Partnering
This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of...
$995
 
Displaying 1 to 30 (of 1534 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData